
State-of-the-art testing options, including DNA- and RNA-based next-generation sequencing (NGS)

A suite of pan-tumor and disease-specific panels to match the right test to the right indication

Solid tumor liquid biopsy testing to provide minimally invasive genomic testing solutions

Access to a center of excellence for specimen procurement services, including mobile phlebotomy and solid tissue block retrieval

Patient support teams that will partner with you to help your patients navigate their testing journey
Testing solutions by disease area

Breast cancer

Lung cancer

Colorectal cancer

Hematologic cancer

Gastric cancer
Featured tests
Neo Comprehensive - Solid Tumor
Neo Comprehensive - Myeloid Disorders
InVisionFirst®-Lung Liquid Biopsy
InVisionFirst®-Lung Liquid Biopsy is a 37-gene NGS-based liquid biopsy to detect oncogenic driver mutations and therapy targets in NSCLC.